Syndax
Nate Ide has over 20 years of experience in the pharmaceutical industry. Nate has held various roles in market access, trade relations, and national accounts. Prior to their current role as Vice President of Market Access and Trade Relations at Syndax Pharmaceuticals since November 2019, Nate was Head of Trade Relations at LOXO Oncology and Churchill Pharmaceuticals. Nate also served as Vice President of Market Access and Trade Relations at entrinsic bioscience and Galena Biopharma. Earlier in their career, Nate held senior positions at Spectrum Pharmaceuticals, MGI Pharma, Roche, and Zeneca.
Nate Ide received their Bachelor of Arts (B.A.) degree in Communications from the University of Rhode Island, where they attended from 1991 to 1995.
This person is not in any teams
This person is not in any offices
Syndax
Syndax Pharmaceuticals, Inc (Syndax) is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The Company’s product candidate, entinostat, which was granted Breakthrough The...